Case Investigations

SolarCity Corporation

March 25, 2014 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating San Mateo, California-based SolarCity Corporation (“Solar City” or the “Company”) (Nasdaq: SCTY) for potential violations of the federal securities laws.  Investors who purchased SolarCity securities may be affected.

Hyperdynamics Corporation

March 14, 2014 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Houston, Texas-based Hyperdynamics Corporation ("Hyperdynamics" or the “Company”) (NYSE: HDY) for potential violations of the federal securities laws.  Investors who purchased Hyperdynamics securities between November 8, 2012 and March 11, 2014 (the "Class Period") may be affected.

Addus HomeCare Corporation

March 14, 2014 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Palatine, Illinois-based Addus HomeCare Corporation ("Addus HomeCare" or the “Company”) (Nasdaq: ADUS) for potential violations of the federal securities laws.  Investors who purchased Addus HomeCare common stock may be affected.

MagnaChip Semiconductor Corporation

March 12, 2014 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating MagnaChip Semiconductor Corporation ("MagnaChip" or the “Company”) (NYSE: MX) for potential violations of the federal securities laws.  Investors who purchased MagnaChip securities may be affected.

ITT Educational Services, Inc.

San Francisco – March 3, 2014 - Kaplan Fox & Kilsheimer LLP (“Kaplan Fox”) (www.kaplanfox.com) is investigating potential claims on behalf of current or former students of ITT Technical Institutes...

St. Joseph Health System

San Francisco – February 14, 2014 - Kaplan Fox Investigates Claims Involving A Cyber Security Attack at St. Joseph Health System in Bryan, Texas.

AHMC Healthcare, Inc.

San Francisco – January 9, 2014 - Kaplan Fox & Kilsheimer LLP (“Kaplan Fox”) (www.kaplanfox.com) is investigating potential claims involving the theft of two laptops on October 12, 2013 from a secured office of AHMC Healthcare Inc....

Sanchez Energy Corp.

November 12, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Sanchez Energy Corp. On November 11, 2013, The Wall Street Journal published a story concerning Sanchez Energy’s all-in-the-family deals (click here)...

Velocity Investment Group and the Bio Profit Funds

November 5, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Velocity Investment Group and the Bio Profit Funds (Bio Profit Series I, LLC ("BPS I"), Bio Profit Series II, LLC ("BPS II"), Bio Profit Series III, LLC ("BPS III") and Bio Profit Series V, LLC ("BPS V"))...

Revel Casino Hotel

San Francisco – October 11, 2013 - Kaplan Fox & Kilsheimer LLP is investigating potential claims that the offer made to consumers by Revel Entertainment Group and Chatham Asset Management in the "Refund All Slot Losses" campaign, effective during the month of July, 2013 at the Revel Casino Hotel in Atlantic City, was misleading and deceptive.

Adobe Systems, Inc.

San Francisco – October 11, 2013 - Kaplan Fox & Kilsheimer LLP is investigating potential claims involving Adobe Systems Inc.’s public announcement on October 3, 2013 that it had discovered “sophisticated attacks” on its network, “involving the illegal access of customer information."

Honeywell International, Inc.

September 9, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Honeywell International, Inc. (“Honeywell”), for potential violations of state consumer fraud laws in connection with the manufacturing and sale of defective LPT1 and LPT2 blade retainers in Honeywell aircraft engines.

Life Insurers: Hartford Financial Services Group, Met Life, ING U.S. Transamerica, etc.

June 26, 2013 - If you own an annuity issued by the Hartford Financial Services Group, Met Life, ING U.S. Transamerica, or other U.S.-based life insurer, you need to take steps to protect your investment. It was been widely reported that life insurers in the U.S. are exploring to reduce the liability they face from annuities at the expense of investors by cancelling lifetime incomes guarantees.

Crestor® (rosuvastatin calcium)

May 25, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating the statin drug Crestor® (rosuvastatin), a cholesterol-lowering medication, approved by the Food and Drug Administration for use by the public in August 2003.